Biochemical Pharmacology of the Sigma-1 Receptor
暂无分享,去创建一个
[1] T. Su,et al. Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid , 2015, Proceedings of the National Academy of Sciences.
[2] N. Natsvlishvili,et al. Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria , 2015, BMC Biochemistry.
[3] Deo R. Singh,et al. The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. , 2015, The Biochemical journal.
[4] H. Hara,et al. Effect of a sigma-1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage. , 2015, Experimental eye research.
[5] J. Schnell,et al. Solution NMR studies reveal the location of the second transmembrane domain of the human sigma-1 receptor , 2015, FEBS letters.
[6] M. Sokabe,et al. Sigma-1 (σ1) receptor deficiency reduces β-amyloid25–35-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B , 2015, Neuropharmacology.
[7] T. Mavlyutov,et al. Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS) , 2015, Journal of pharmacological sciences.
[8] T. Su,et al. Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders , 2014, Expert opinion on therapeutic targets.
[9] J. Edwardson,et al. A Direct Interaction between the Sigma-1 Receptor and the hERG Voltage-gated K+ Channel Revealed by Atomic Force Microscopy and Homogeneous Time-resolved Fluorescence (HTRF®)* , 2014, The Journal of Biological Chemistry.
[10] Adrian Y. C. Wong,et al. NMDA Receptors Are Upregulated and Trafficked to the Plasma Membrane after Sigma-1 Receptor Activation in the Rat Hippocampus , 2014, The Journal of Neuroscience.
[11] B. Fox,et al. The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands , 2014, The Journal of Biological Chemistry.
[12] K. Klempnauer,et al. The sigma enigma: in vitro/in silico site-directed mutagenesis studies unveil σ1 receptor ligand binding. , 2014, Biochemistry.
[13] B. Kobilka,et al. The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin. , 2014, Current opinion in cell biology.
[14] Andrew P. Stewart,et al. The σ-1 Receptor Interacts Directly with GluN1 But Not GluN2A in the GluN1/GluN2A NMDA Receptor , 2013, The Journal of Neuroscience.
[15] Teruo Hayashi,et al. Sigma-1 Receptor Chaperone at the ER-Mitochondrion Interface Mediates the Mitochondrion-ER-Nucleus Signaling for Cellular Survival , 2013, PloS one.
[16] S. Pricl,et al. Structure of the σ1 receptor and its ligand binding site. , 2013, Journal of medicinal chemistry.
[17] T. Mavlyutov,et al. Lack of sigma-1 receptor exacerbates ALS progression in mice , 2013, Neuroscience.
[18] J. Schnell,et al. Characterization of the Human Sigma-1 Receptor Chaperone Domain Structure and Binding Immunoglobulin Protein (BiP) Interactions* , 2013, The Journal of Biological Chemistry.
[19] B. Fox,et al. Improved expression and purification of sigma 1 receptor fused to maltose binding protein by alteration of linker sequence. , 2013, Protein expression and purification.
[20] A. Hajipour,et al. Photoaffinity labeling of the sigma-1 receptor with N-[3-(4-nitrophenyl)propyl]-N-dodecylamine: evidence of receptor dimers. , 2013, Biochemistry.
[21] S. Kourrich,et al. Dynamic Interaction between Sigma-1 Receptor and Kv1.2 Shapes Neuronal and Behavioral Responses to Cocaine , 2013, Cell.
[22] I. Katona,et al. Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis. , 2013, Human molecular genetics.
[23] Teruo Hayashi,et al. The Lifetime of UDP-galactose:Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones* , 2012, The Journal of Biological Chemistry.
[24] E. Sigel,et al. Structure, Function, and Modulation of GABAA Receptors* , 2012, The Journal of Biological Chemistry.
[25] Andrew P. Stewart,et al. The Sigma-1 Receptor Binds to the Nav1.5 Voltage-gated Na+ Channel with 4-Fold Symmetry* , 2012, The Journal of Biological Chemistry.
[26] X. Navarro,et al. Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice , 2012, Neurotherapeutics.
[27] Teruo Hayashi,et al. Compromising σ-1 Receptors at the Endoplasmic Reticulum Render Cytotoxicity to Physiologically Relevant Concentrations of Dopamine in a Nuclear Factor-κB/Bcl-2-Dependent Mechanism: Potential Relevance to Parkinson's Disease , 2012, Journal of Pharmacology and Experimental Therapeutics.
[28] Z. Janka,et al. Association between a variant of the sigma-1 receptor gene and Alzheimer's disease , 2012, Neuroscience Letters.
[29] J. Markley,et al. The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. , 2012, European journal of pharmacology.
[30] Jennifer A. Mirrielees,et al. Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands , 2012, Brain Research.
[31] P. Liu,et al. Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N′-dimethyltryptamine forming enzyme, indole-N-methyl transferase , 2012, Neuroscience.
[32] Heather A. O'Neill,et al. Small heat shock proteins and α-crystallins: dynamic proteins with flexible functions. , 2012, Trends in biochemical sciences.
[33] A. Hajipour,et al. The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines. , 2012, Current pharmaceutical design.
[34] F. Al-Mohanna,et al. A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis , 2011, Annals of neurology.
[35] A. Hajipour,et al. Characterization of interactions of 4-nitrophenylpropyl-N-alkylamine with ς receptors. , 2011, Biochemistry.
[36] R. Nickells,et al. Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor , 2011, Molecular vision.
[37] S. Buch,et al. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. , 2010, Trends in pharmacological sciences.
[38] P. Schofield,et al. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration–motor neuron disease , 2010, Annals of neurology.
[39] K. Fuxe,et al. Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine , 2010, Proceedings of the National Academy of Sciences.
[40] T. Mavlyutov,et al. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study , 2010, Neuroscience.
[41] Jean-Christophe Gelly,et al. Detection and Architecture of Small Heat Shock Protein Monomers , 2010, PloS one.
[42] M. Jackson,et al. Demonstration of a direct interaction between sigma-1 receptors and acid-sensing ion channels. , 2010, Biophysical journal.
[43] G. Pasternak,et al. σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding , 2010, Molecular Pharmacology.
[44] M. Kudo,et al. SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression , 2010, Neuroscience Letters.
[45] K. Becker,et al. Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1·GTP pathway , 2009, Proceedings of the National Academy of Sciences.
[46] P. Stewart,et al. Structure and mechanism of protein stability sensors: chaperone activity of small heat shock proteins. , 2009, Biochemistry.
[47] S. Pyne,et al. The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. , 2009, European journal of pharmacology.
[48] M. Jackson,et al. The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.
[49] A. Dibas,et al. Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. , 2008, Investigative ophthalmology & visual science.
[50] W. Bowen,et al. Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation , 2008, Journal of Biological Chemistry.
[51] V. Ganapathy,et al. In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. , 2008, Investigative ophthalmology & visual science.
[52] A. Hajipour,et al. Juxtaposition of the Steroid Binding Domain-like I and II Regions Constitutes a Ligand Binding Site in the σ-1 Receptor* , 2008, Journal of Biological Chemistry.
[53] I. Horváth,et al. Membrane-associated stress proteins: more than simply chaperones. , 2008, Biochimica et biophysica acta.
[54] A. Hajipour,et al. Probing the steroid binding domain-like I (SBDLI) of the sigma-1 receptor binding site using N-substituted photoaffinity labels. , 2008, Biochemistry.
[55] Yusuf A. Hannun,et al. Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.
[56] E. Aydar,et al. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. , 2007, Cancer research.
[57] Teruo Hayashi,et al. Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.
[58] A. Hajipour,et al. Identification of Regions of the σ-1 Receptor Ligand Binding Site Using a Novel Photoprobe , 2007, Molecular Pharmacology.
[59] T. Mavlyutov,et al. Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells , 2007, Journal of molecular signaling.
[60] A. Hajipour,et al. Characterization of the cocaine binding site on the sigma-1 receptor. , 2007, Biochemistry.
[61] A. Ruoho,et al. Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli. , 2007, Protein expression and purification.
[62] H. Guizouarn,et al. Cancer Cell Cycle Modulated by a Functional Coupling between Sigma-1 Receptors and Cl– Channels* , 2007, Journal of Biological Chemistry.
[63] S. Milstien,et al. Functions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives* , 2007, Journal of Biological Chemistry.
[64] F. Drago,et al. Sigma receptor ligands protect human retinal cells against oxidative stress , 2006, Neuroreport.
[65] Glennon Ra. Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach. , 2005 .
[66] T Sasaki,et al. Function of sigma1 receptors in Parkinson's disease , 2005, Acta neurologica Scandinavica.
[67] Teruo Hayashi,et al. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[68] K. Blumer,et al. Oligomerization, Biogenesis, and Signaling Is Promoted by a Glycophorin A-like Dimerization Motif in Transmembrane Domain 1 of a Yeast G Protein-coupled Receptor* , 2003, Journal of Biological Chemistry.
[69] G. Milligan. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. , 2003, Molecular pharmacology.
[70] J. Carver,et al. Small Heat‐shock Proteins and Clusterin: Intra‐ and Extracellular Molecular Chaperones with a Common Mechanism of Action and Function? , 2003, IUBMB life.
[71] Teruo Hayashi,et al. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. , 2003, Current medicinal chemistry.
[72] Teruo Hayashi,et al. σ-1 Receptors (σ1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export , 2003, Journal of Pharmacology and Experimental Therapeutics.
[73] J. Cuevas,et al. Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. , 2002, Journal of neurophysiology.
[74] Mark R. Wilson,et al. Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin. , 2002, European journal of biochemistry.
[75] Meyer B. Jackson,et al. The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit , 2002, Neuron.
[76] Andrew Coop,et al. N-arylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agents. , 2002, Bioorganic & medicinal chemistry letters.
[77] P. Casellas,et al. Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. , 2001, Biochimica et biophysica acta.
[78] Teruo Hayashi,et al. Regulating ankyrin dynamics: Roles of sigma-1 receptors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[79] J. Carver,et al. Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. , 2000, Biochemistry.
[80] H. Nakayama,et al. (2R-trans)-2-butyl-5-heptylpyrrolidine as a potent sigma receptor ligand produced by Streptomyces longispororuber. , 2000, The Journal of antibiotics.
[81] M. Wilson,et al. Clusterin is a secreted mammalian chaperone. , 2000, Trends in biochemical sciences.
[82] V. Ganapathy,et al. Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. , 1999, The Journal of pharmacology and experimental therapeutics.
[83] S. Okuyama,et al. Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding , 1999, FEBS letters.
[84] B. Kobilka,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[85] H. Glossmann,et al. High affinity of sigma1‐binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8–C7 isomerase , 1997, British journal of pharmacology.
[86] H. Glossmann,et al. Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. , 1996, Biochemistry.
[87] E. Kempner,et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[88] E. Schmid,et al. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. , 1993, Molecular pharmacology.
[89] A. Ruoho,et al. (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[90] W. Bowen,et al. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain , 1990, Brain Research.
[91] C. Montigny,et al. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors , 1990 .
[92] W. Bowen,et al. Synthesis and evaluation of optically pure [3H]‐(+)‐pentazocine, a highly potent and selective radioligand for σ receptors , 1989 .
[93] W. Bowen,et al. Evidence for a multi-site model of the rat brain σ receptor , 1989 .
[94] M. Kuhar,et al. Cocaine binding at σ receptors , 1988 .
[95] E. London,et al. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. , 1988, Science.
[96] S. Mclean,et al. Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain , 1988, Neuroscience.
[97] S. Snyder,et al. Structural determinants of sigma receptor affinity. , 1987, Molecular pharmacology.
[98] Y. Itzhak. [3H]PCP-3-OH and (+)[3H]SKF 10047 binding sites in rat brain membranes: evidence of multiplicity. , 1987, European journal of pharmacology.
[99] M. Sonders,et al. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[100] S. Snyder,et al. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. , 1986, The Journal of pharmacology and experimental therapeutics.
[101] J. Ieni,et al. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality. , 1986, The Journal of pharmacology and experimental therapeutics.
[102] S. Tam,et al. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[103] S. Snyder,et al. Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[104] W R Martin,et al. Pharmacology of opioids. , 1983, Pharmacological reviews.
[105] S. Tam. Naloxone-inaccessible sigma receptor in rat central nervous system. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[106] D. B. Vaupel,et al. Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog , 1983 .
[107] T. Su. Psychotomimetic opioid binding: specific binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. , 1981, European journal of pharmacology.
[108] J. Thompson,et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.
[109] B. Lucke-Wold,et al. Role of sigma-1 receptors in neurodegenerative diseases. , 2015, Journal of pharmacological sciences.
[110] K. Fukunaga,et al. The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis. , 2015, Journal of pharmacological sciences.
[111] 吐尔洪 吐尔逊. SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression , 2010 .
[112] E. Albuquerque,et al. Mammalian nicotinic acetylcholine receptors: from structure to function. , 2009, Physiological reviews.
[113] Teruo Hayashi,et al. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. , 2007, Cell.
[114] A. Hajipour,et al. Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. , 2007, Molecular pharmacology.
[115] R. Glennon. Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach. , 2005, Mini reviews in medicinal chemistry.
[116] Teruo Hayashi,et al. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. , 2003, The Journal of pharmacology and experimental therapeutics.
[117] R. V. van Montfort,et al. Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. , 2001, Advances in protein chemistry.
[118] Obradovic,et al. Predicting Binding Regions within Disordered Proteins. , 1999, Genome informatics. Workshop on Genome Informatics.
[119] Obradovic,et al. Predicting Protein Disorder for N-, C-, and Internal Regions. , 1999, Genome informatics. Workshop on Genome Informatics.
[120] Kay Hofmann,et al. Tmbase-A database of membrane spanning protein segments , 1993 .
[121] G. Debonnel,et al. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. , 1990, European journal of pharmacology.
[122] M. Kavanaugh,et al. Solubilization and characterization of sigma-receptors from guinea pig brain membranes. , 1989, Journal of Neurochemistry.
[123] W. Bowen,et al. Evidence for a multi-site model of the rat brain sigma receptor. , 1989, European journal of pharmacology.
[124] W. Bowen,et al. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors. , 1989, FEBS letters.
[125] M. Kuhar,et al. Cocaine binding at sigma receptors. , 1988, European journal of pharmacology.
[126] L. Snell,et al. Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands. , 1986, NIDA research monograph.
[127] D. B. Vaupel,et al. Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog. , 1983, European journal of pharmacology.